查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1715414

免疫血液學市場按產品類型、應用和最終用戶分類－2025-2030 年全球預測

Immunohematology Market by Product Type, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計免疫血液學市場在 2024 年的價值將達到 22.2 億美元，在 2025 年成長至 24 億美元，到 2030 年將達到 35.9 億美元，複合年成長率為 8.27%。

主要市場統計數據
基準年2024年 22.2億美元
預計2025年 24億美元
預測年份 2030 35.9億美元
複合年成長率（%） 8.27%

隨著技術進步和實踐發展共同重新定義診斷和患者照護，免疫血液學領域正處於一個令人興奮的十字路口。血液相容性測試、抗體檢測和先進系統整合領域的最新技術進步正在將傳統的實驗室工作流程轉變為更簡化、準確和自動化的流程。本介紹性概述深入探討了提高免疫血液學服務的分析準確性和業務效率的進展，為本文奠定了基礎。近年來，新技術徹底改變了常規協議，推動了從手動程序到更先進的自動化系統的模式轉移。此外，對更快、更準確的測試結果的需求正在加速對新試劑、系統和診斷平台的投資。隨著研究人員和決策者尋求利用這些尖端能力，這種轉變反映了醫療保健領域的更廣泛趨勢，其中資料主導的洞察力和創新解決方案正在成為改善患者治療結果的重要組成部分。

隨著對精準診斷和技術無縫整合的日益重視，這種動態格局使免疫血液學成為創新的沃土。該報告深入說明了推動市場發展的因素、滿足特定產品和用戶需求的細分分析以及影響市場動態的區域差異。這項全面的分析旨在為行業相關人員提供他們所需的洞察力，以駕馭和利用當前趨勢，確保他們的實驗室服務不僅滿足當前需求，而且還為未來做好準備。

重新定義免疫血液學診斷的變革性轉變

免疫血液學的發展以變革性的變化為標誌，重新定義了整個診斷領域。近年來，自動化和數位化整合取代了傳統的檢測方法，為提高準確性、效率和吞吐量鋪平了道路。實驗室採用最先進的分析設備和系統，不僅加快了測試過程，而且還確保了整個診斷過程的品質始終如一。這種轉變是由不斷提高業務績效的動力和對支援更快臨床決策的整合式資料管理系統日益成長的需求所推動的。

全自動系統的進步顯著提高了抗體檢測的敏感度和特異性，從而降低了人為錯誤的風險並提高了整體診斷信心。相關人員也看到對半自動化平台的需求激增，這些平台可以靈活處理複雜的診斷場景並在自動化和手動監督之間取得平衡。對全面診斷覆蓋的需求，以及業界對資源最佳利用的關注，正在推動對技術創新和研究型舉措的強勁投資。因此，這種轉變不僅重新定義了目前的臨床實踐，而且為免疫血液學檢測的可靠性和效率設定了新的基準。

深入了解免疫血液學檢查的關鍵領域

對市場的詳細研究揭示了複雜的細分動態，為免疫血液學提供了關鍵見解。分析主要分為三個維度。首先，從產品類型來看，市場是依照分析設備和系統等儀器與試劑、套件等結合來分析的。透過評估分析儀器和系統子區隔可以獲得更深入的理解。此子區隔進一步分為提供高吞吐量的全自動平台和允許手動控制的半自動化選項。這種細緻的分類可以對各種實驗室環境中的技術層級和產品採用率進行詳細評估。

其次，基於應用的細分突顯了免疫血液學系統在幾個關鍵測試領域的多樣化效用。該框架包括抗體篩檢、輸血安全通訊協定、準確的疾病診斷、妊娠監測等，每個方面都在推動市場成長方面發揮著至關重要的作用。橫斷面分析提供了對每個應用如何促進整體市場需求的洞察，並強調了當前診斷解決方案所解決的獨特挑戰。

此外，市場根據最終用戶進行細分，以滿足血庫、診斷實驗室、醫院和研究機構等不同機構的不同需求。這種分類有助於理解採購模式、預算分配和特定服務要求的差異。透過交叉分析產品類型、應用和最終用戶的細微差別，細分分析不僅可以揭示當前的市場狀況，還可以幫助確定未來創新和擴張的機會。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 血液疾病和自體免疫疾病的盛行率不斷上升，推動了對詳細檢測的需求。
      • 加強公眾意識和教育宣傳活動，促進安全捐血和血液檢測實踐
      • 擴大政府投資和公共衛生舉措，提高血液安全標準
    • 限制因素
      • 先進診斷設備及耗材試劑高成本
    • 機會
      • 擴大分子診斷和基因分型工具在輸血醫學中的應用，以支持免疫血液學環境中的個人化治療計劃
      • 免疫血液學診斷的技術進步和自動化程度的提高正在提高檢測的準確性和操作效率。
    • 任務
      • 複雜的監管要求和漫長的核准時間阻礙了產品的快速推出
  • 市場區隔分析
    • 產品類型：大型血庫和臨床實驗室擴大採用分析儀和系統
    • 應用：增加免疫血液學在懷孕期間篩檢母體抗體的應用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

6. 免疫血液學市場（依產品類型）

  • 分析儀器和系統
    • 全自動
    • 半自動
  • 試劑和套件

第7章免疫血液學市場：依應用

  • 抗體篩檢
  • 輸血
  • 疾病診斷
  • 懷孕

第 8 章 免疫血液學市場（依最終使用者）

  • 血庫
  • 診斷實驗室
  • 醫院
  • 研究組織

9.美洲免疫血液學市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

10. 亞太免疫血液學市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第 11 章歐洲、中東和非洲免疫血液學市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • Abbott Laboratories
  • AliveDx Suisse SA
  • Beckman Coulter, Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biomed Global
  • Cardinal Health, Inc.
  • CSL Limited
  • DIAGAST
  • F. Hoffmann-La Roche Ltd.
  • Grifols, SA
  • Immucor, Inc.
  • Merck KGaA
  • QuidelOrtho Corporation
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • VWR International, LLC.
Product Code: MRR-43127F7279CA

The Immunohematology Market was valued at USD 2.22 billion in 2024 and is projected to grow to USD 2.40 billion in 2025, with a CAGR of 8.27%, reaching USD 3.59 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 2.22 billion
Estimated Year [2025] USD 2.40 billion
Forecast Year [2030] USD 3.59 billion
CAGR (%) 8.27%

The field of immunohematology stands at an exciting juncture as technological advancements and evolving practices converge to redefine diagnostics and patient care. In the realm of blood compatibility testing, antibody detection, and advanced system integrations, recent innovations have transformed traditional laboratory workflows into more streamlined, accurate, and automated processes. This introductory overview sets the stage by delving into how advancements have bolstered the analytical accuracy and operational efficiency of immunohematology services. Over the past few years, emerging technologies have led to a comprehensive re-assessment of routine protocols, driving a paradigm shift from manual testing techniques to more sophisticated automated systems. Further, the demand for both faster turnarounds and precision in test results has accelerated investment in novel reagents, systems, and diagnostic platforms. As researchers and decision-makers look to harness these cutting-edge capabilities, the transformation reflects broader trends within healthcare, where data-driven insights and innovative solutions are becoming essential ingredients for improved patient outcomes.

This dynamic landscape, punctuated by an increasing emphasis on precision diagnostics and seamless integration of technology, makes immunohematology a fertile ground for innovation. The ensuing discussion is intricately designed to provide a detailed exploration of the drivers behind market evolution, segmented analysis that addresses product and user-specific needs, and the regional disparities that shape market dynamics. This comprehensive analysis aims to equip industry stakeholders with the insights necessary to navigate and leverage current trends, ensuring that laboratory services not only meet current demands but also remain future-ready.

Transformative Shifts Redefining Immunohematology Diagnostics

The evolution of immunohematology is marked by transformative shifts that have redefined the entire diagnostic landscape. In recent years, automation and digital integration have supplanted conventional testing methodologies, paving the way for enhanced accuracy, efficiency, and throughput. Laboratories are adopting cutting-edge analyzers and systems which not only accelerate the testing process but also ensure consistent quality across diagnostic procedures. This shift is driven by the relentless pursuit of improved operational performance and the increasing need for integrated data management systems that support rapid clinical decision-making.

Advancements in fully-automated systems have introduced significant improvements in the sensitivity and specificity of antibody detection, thereby reducing the risk of human error and enhancing overall diagnostic confidence. Stakeholders have also witnessed a surge in the demand for semi-automated platforms, which strike a balance between automation and manual oversight, offering flexibility in handling complex diagnostic scenarios. The industry's focus on optimal resource utilization, alongside the need for comprehensive diagnostic coverage, has stimulated robust investment across both technological innovations and research-oriented initiatives. Consequently, these transformative changes are not only redefining current practices but are also setting new benchmarks for reliability and efficiency in immunohematology testing.

Key Segmentation Insights in Immunohematology

A closer examination of the market reveals intricate segmentation dynamics that provide critical insights into the immunohematology landscape. The analysis is subdivided primarily along three dimensions. First, in terms of product type, the market is analyzed through the lens of devices such as analyzers and systems paired with reagents and kits. An in-depth understanding is offered by evaluating the sub-segment of analyzers and systems, which is further segmented into fully-automated platforms that offer high throughput and semi-automated options that allow for controlled human input. This nuanced categorization enables a detailed appraisal of the technological hierarchy and product adoption rates across various laboratory settings.

Next, the segmentation based on application underscores the diversified utility of immunohematology systems across several critical testing domains. The framework encompasses antibody screening, blood transfusion safety protocols, precise disease diagnosis, and monitoring pregnancy, each playing a vital role in driving market growth. The cross-sectional analysis provides insights into how each application contributes to overall market demand and highlights the unique challenges addressed by current diagnostic solutions.

Furthermore, the market is segmented by end-users, capturing the differential needs across institutions such as blood banks, diagnostic laboratories, hospitals, and research institutes. This categorization is instrumental in understanding the variances in procurement patterns, budget allocations, and service-specific requirements. By interlacing the nuances of product type, application, and end-user, the segmentation analysis not only illuminates the market's current state but also helps pinpoint future opportunities for innovation and expansion.

Based on Product Type, market is studied across Analyzers & Systems and Reagents & Kits. The Analyzers & Systems is further studied across Fully-Automated and Semi-Automated.

Based on Application, market is studied across Antibody Screening, Blood Transfusion, Disease Diagnosis, and Pregnancy.

Based on End-User, market is studied across Blood Banks, Diagnostic Laboratories, Hospitals, and Research Institutes.

Global Regional Perspectives in Immunohematology

Regional perspectives offer a multi-faceted view of the global immunohematology market, highlighting both mature and emerging sectors. In the Americas, a strong emphasis on advanced healthcare technologies and significant investment in research and development has positioned the region as one of the prominent hubs for implementing sophisticated diagnostic solutions. Conversely, the Europe, Middle East & Africa cluster demonstrates a diverse range of practices where traditional methodologies are being rapidly supplemented by modern technological interventions, ensuring a delicate balance between legacy systems and innovative instruments. In the Asia-Pacific region, rapid urbanization combined with increasing investments in healthcare infrastructure is fostering an environment ripe for adoption of next-generation diagnostic platforms. This regional analysis showcases the interplay between economic growth, healthcare policies, and technological advancements in shaping the landscape of immunohematology.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Insights into Leading Industry Players Driving Innovation

A review of key market players offers additional layers of insight into competitive strategies and technological trends that dominate the immunohematology sector. Industry leaders such as Abbott Laboratories and AliveDx Suisse SA continue to push the envelope in diagnostic innovation, setting benchmark standards for product efficacy and reliability. Organizations like Beckman Coulter, Inc. and Becton Dickinson and Company have shown consistent commitment to integrating automation into clinical practices. Other notable contributors including Bio-Rad Laboratories, Inc. and Biomed Global, as well as Cardinal Health, Inc. and CSL Limited, have successfully combined rigorous research with product development to address gaps in the market.

The influence extends further through companies like DIAGAST and F. Hoffmann-La Roche Ltd., whose research-driven initiatives catalyze new product lines. Grifols, S.A. and Immucor, Inc. are recognized for their role in enhancing operational efficiencies in blood banks and diagnostic labs. Industry giants such as Merck KGaA and QuidelOrtho Corporation provide robust solutions that span a variety of diagnostic applications, while Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific, Inc., and VWR International, LLC lead the pack with their expansive portfolios that continually raise the bar in terms of clinical precision and patient outcomes. The cumulative efforts of these market players underscore a competitive yet collaborative drive towards innovation in immunohematology.

The report delves into recent significant developments in the Immunohematology Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AliveDx Suisse SA, Beckman Coulter, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Biomed Global, Cardinal Health, Inc., CSL Limited, DIAGAST, F. Hoffmann-La Roche Ltd., Grifols, S.A., Immucor, Inc., Merck KGaA, QuidelOrtho Corporation, Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific, Inc., and VWR International, LLC.. Actionable Recommendations to Strengthen Market Leadership

For industry leaders navigating this complex and rapidly evolving landscape, strategic initiatives are imperative to maintain a competitive edge. Key recommendations include investing in integrated diagnostic platforms that combine automation with cutting-edge research to enhance test accuracy and operational efficiency. Leaders should consider forging strategic alliances with technology providers to develop robust systems that respond to the growing demand for both fully-automated and semi-automated solutions, ensuring a scalable approach to laboratory modernization.

Moreover, diversification in product portfolios coupled with an emphasis on customized solutions tailored to the unique needs of different testing applications-ranging from antibody screening to disease diagnosis-will prove to be a crucial differentiator. Embracing data analytics to forecast market trends, optimizing supply chain operations, and maintaining agility in response to regulatory changes also remain top priorities. By aligning operational strategies with evolving market dynamics, decision-makers can not only cement their leadership position in the immunohematology space but also drive sustainable growth and innovation.

Synthesis and Forward-Looking Perspectives

In conclusion, the immunohematology landscape is witnessing an unprecedented convergence of innovation, operational refinement, and evolving consumer expectations. The insights shared through the segmentation, regional analysis, and competitive landscape underscore the transformative potential of technological advancements and strategic investment. As laboratories and healthcare institutions increasingly embrace modern diagnostic tools, the necessity for integrated, efficient, and precise systems becomes more critical than ever. Industry stakeholders must leverage these insights to navigate challenges, capitalize on emerging trends, and drive operational excellence across all facets of immunohematology.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of hematological disorders and autoimmune diseases driving demand for precise testing
      • 5.1.1.2. Rising public awareness and education campaigns promoting safe blood donation and screening practices
      • 5.1.1.3. Growing government investments and public health initiatives aimed at enhancing blood safety standards
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of advanced diagnostic equipment and consumable reagents
    • 5.1.3. Opportunities
      • 5.1.3.1. Expanding the use of molecular diagnostics and genotyping tools in transfusion medicine to support personalized treatment plans in immunohematology settings
      • 5.1.3.2. Technological advancements in immunohematology diagnostics coupled with automation improvements are enhancing test accuracy and operational efficiency
    • 5.1.4. Challenges
      • 5.1.4.1. Complex regulatory requirements and prolonged approval timelines that hinder swift product introductions
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Rising adoption of analyzers & systems for high-volume blood banks and clinical laboratories
    • 5.2.2. Application: Growing application of immunohematology in pregnancy to screen for maternal antibodies
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Immunohematology Market, by Product Type

  • 6.1. Introduction
  • 6.2. Analyzers & Systems
    • 6.2.1. Fully-Automated
    • 6.2.2. Semi-Automated
  • 6.3. Reagents & Kits

7. Immunohematology Market, by Application

  • 7.1. Introduction
  • 7.2. Antibody Screening
  • 7.3. Blood Transfusion
  • 7.4. Disease Diagnosis
  • 7.5. Pregnancy

8. Immunohematology Market, by End-User

  • 8.1. Introduction
  • 8.2. Blood Banks
  • 8.3. Diagnostic Laboratories
  • 8.4. Hospitals
  • 8.5. Research Institutes

9. Americas Immunohematology Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Immunohematology Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Immunohematology Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2024
  • 12.2. FPNV Positioning Matrix, 2024
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Zoetis launches a cartridge-based AI hematology analyzer designed to revolutionize immunohematology diagnostics
    • 12.3.2. Massive Bio's launch of the Synergy-AI platform at ASCO 2024 transforms clinical trial matching
    • 12.3.3. Sysmex and CellaVision extend their strategic alliance until 2038 to integrate next-generation cell morphology analyzers
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AliveDx Suisse SA
  • 3. Beckman Coulter, Inc.
  • 4. Becton Dickinson and Company
  • 5. Bio-Rad Laboratories, Inc.
  • 6. Biomed Global
  • 7. Cardinal Health, Inc.
  • 8. CSL Limited
  • 9. DIAGAST
  • 10. F. Hoffmann-La Roche Ltd.
  • 11. Grifols, S.A.
  • 12. Immucor, Inc.
  • 13. Merck KGaA
  • 14. QuidelOrtho Corporation
  • 15. Siemens Healthineers AG
  • 16. Sysmex Corporation
  • 17. Thermo Fisher Scientific, Inc.
  • 18. VWR International, LLC.

LIST OF FIGURES

  • FIGURE 1. IMMUNOHEMATOLOGY MARKET MULTI-CURRENCY
  • FIGURE 2. IMMUNOHEMATOLOGY MARKET MULTI-LANGUAGE
  • FIGURE 3. IMMUNOHEMATOLOGY MARKET RESEARCH PROCESS
  • FIGURE 4. IMMUNOHEMATOLOGY MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 15. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 17. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. IMMUNOHEMATOLOGY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 23. IMMUNOHEMATOLOGY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. IMMUNOHEMATOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IMMUNOHEMATOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY FULLY-AUTOMATED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY SEMI-AUTOMATED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY ANTIBODY SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY PREGNANCY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. IMMUNOHEMATOLOGY MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 192. IMMUNOHEMATOLOGY MARKET, FPNV POSITIONING MATRIX, 2024